UB

University of Barcelona

Information
Gran Via de les Corts Catalanes, 585

addictions, Alzheimer's, Antarctica / Arctic, astrobiology, astrophysics, big data, bioethics, climate change, cancer, behavioural sciences, natural sciences, climate, quantum computing, pollution, covid-19, embryonic development, diabetes, gene editing, education, energy, cardiovascular diseases, neurodegenerative diseases, rare diseases, ageing, epidemiology, STDs, physics, immunology, language, mathematics, microbiology, nanoscience, neuroscience, new materials, oceanography, palaeontology, chemistry, robotics, mental health, AIDS / HIV, sociology, supercomputing, transgenics
Contact
Ester Colominas
Head of Institutional Communication Unit
premsa@ub.edu
934035544

If you are the contact person for this centre and you wish to make any changes, please contact us.

SMC participants

Doctor in Biology and research professor in the Department of Evolutionary Biology, Ecology, and Environmental Sciences at the University of Barcelona.

Ramón y Cajal researcher at the Institute of Neurosciences at the University of Barcelona

PhD candidate in the Department of Social Psychology and Quantitative Psychology at the Faculty of Psychology, University of Barcelona

ICREA Research Professor and Coordinator of the Regenerative Medicine Programme at the Bellvitge Biomedical Research Institute (IDIBELL), member of CIBER-BBN, Director of the Clinical Translation Programme in Regenerative Medicine in Catalonia, and Professor of Physiology at the University of Barcelona.

Professor of Preventive Medicine and Public Health at the University of Barcelona and member of the Spanish Society of Epidemiology

Associate professor at the University of Barcelona, ICREA Academia fellow, and member of the Scientists’ Coalition for an Effective Plastics Treaty.

Senior Consultant at the Department of Preventive Medicine and Epidemiology at Hospital Clínic in Barcelona, Professor of Public Health and Dean of the Faculty of Medicine and Health Sciences at the University of Barcelona

Professor of Microbiology, University of Barcelona

Researcher at the Applied Research Group on Neuromuscular Diseases at the Sant Joan de Deu Research Institute in Barcelona; at the Department of Genetics, Microbiology and Statistics at the University of Barcelona; and at the Biomedical Research Network Centre for Rare Diseases (CIBERER)

Professor of Cognitive Neuroscience

Brainlab, Department of Clinical Psychology and Psychobiology, University of Barcelona (UB).

UB Institute of Neuroscience

Sant Joan de Déu Research Institute

Lecturer of the Department of Social Psychology and Quantitative Psychology at the University of Barcelona, researcher at the Bellvitge Biomedical Research Institute (IDIBELL) and CIBERSAM

ICREA research professor and leader of the QSBio research group at the University of Barcelona

Head of Microbiology at Hospital Clínic in Barcelona, associate professor at the University of Barcelona, and researcher at ISGlobal Barcelona

Deputy Head of the Tobacco Control Unit at the Catalan Institute of Oncology and lecturer in the Department of Nursing, Public Health, Mental Health and Maternal and Child Health at the University of Barcelona

Lecturer  at the University of Barcelona (UB) and head of the Laboratory of Neural Stem Cells and Brain Damage at the Institute of Neurosciences of the UB

Director of the BCNatal maternal-fetal medicine center (Hospital Clínic-Sant Joan de Déu) and professor at the University of Barcelona.

Head of the Arrhythmias and Physical Activity research group at IDIBAPS, cardiac electrophysiologist at Hospital Clínic Barcelona, associate professor of Medicine at the University of Barcelona and researcher at CIBERCV.

Director of the Institute of Neurosciences at Hospital Clínic, Professor of Psychiatry at the University of Barcelona and researcher at IDIBAPS and CIBERSAM

Professor of Pedagogy at the University of Barcelona 

Lecturer in the Department of Fundamental and Clinical Nursing at the University of Barcelona and member of the research group ‘Bioethics, Law and Society: Interdisciplinary analysis of ethical, legal and social issues of biomedicine, biotechnology and emerging technologies’

Head of Section and Director of the Eating Disorders Unit within the Clinical Psychology Department at Bellvitge University Hospital, Professor at the University of Barcelona, Deputy Director of CIBERobn and ICREA Academia researcher

Professor at the department of Biochemistry and Molecular Biomedicine of the University of Barcelona. Principal Investigator IBUB and CIBEROBN.

Geologist and professor at the Faculty of Earth Sciences, University of Barcelona

Gemma Marfany, Professor of Genetics at the University of Barcelona (UB) and a member of CIBERER, IBUB-IRSJD
 

Serra Húnter Associate Professor at the Faculty of Information and Audiovisual Media of the University of Barcelona

Neuropathologist and Professor Emeritus at the University of Barcelona

Professor of Physical Geography at the University of Barcelona, Director of the Fabra Observatory RACAB

Professor Emeritus of Ecology at the University of Barcelona

Professor of Medicine at the University of Barcelona and coordinator of the Central Sensitisation Unit at the Hospital Clínic de Barcelona.

Associate Professor, Brainlab, Department of Clinical Psychology and Psychobiology, University of Barcelona (UB)

UB Institute of Neurosciences

Sant Joan de Déu Research Institute 

Clinical psychologist in the Department of Child and Adolescent Psychiatry and Psychology at Clínic Hospitaland researcher at IDIBAPS, University of Barcelona

Researcher in the Department of Developmental and Educational Psychology

Scientific coordinator of the National Health System Cancer Strategy, director of the Catalan Oncology Plan and Professor of Preventive Medicine and Public Health at the University of Barcelona

Professor of financial economics and accounting at the University of Barcelona

Researcher in the Human Anatomy and Embryology Unit of the Faculty of Medicine and Health Sciences at the University of Barcelona

Ramón y Cajal Research Professor, Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences

Head of the Research Department and the Technology Department at the Duchenne Parent Project, Spain, and holder of the Chair in Rare Diseases at the University of Barcelona

Physician at the Gynecological Oncology Unit at the Hospital Clínic of Barcelona, ​​scientific coordinator at the Clinical Institute of Gynecology, Obstetrics and Neonatology (ICGON) and associate professor at the University of Barcelona

Professor of Biochemistry and Molecular Biomedicine of the University of Barcelona. Principal Investigator IBUB and CIBEROBN.

Associate professor al University of Barcelona and member of the Department of Biomedical Sciences at Institut of Neuroscience

Professor of Ecology at the University of Barcelona

Serra Húnter Lecturer in the Department of Social Psychology and Quantitative Psychology at the University of Barcelona and co-director of Research at the Jane Goodall Institute Spain and Senegal

Head of Medical Oncology at the Catalan Institute of Oncology (ICO), head of the Colorectal Cancer Research Group, Oncobell programme (IDIBELL) and associate professor of Medicine at the University of Barcelona

 

ICREA research professor of Cosmology and Theoretical Physics at the Institute of Cosmos Sciences at the University of Barcelona, visiting professor in the Astrophysics group at Imperial College London (United Kingdom), and researcher at the Imperial Centre for Inference and Cosmology (ICIC)

Professor of Applied Economics at the University of Barcelona 

Theoretical physicist and ICREA professor at the Institute of Cosmos Sciences of the University of Barcelona

Lecturer Serra Húnter, Department of Biochemistry and Molecular Biomedicine, Faculty of Biology, University of Barcelona

Professor in the Department of Electronics and Biomedical Engineering at the University of Barcelona and group leader at the Institute for Bioengineering of Catalonia

Contents related to this centre
electrode system

The KATRIN (Karlsruhe Tritium Neutrino Experiment) team has published the most accurate measurement to date of the upper limit of the neutrino mass in the journal Science, establishing it at 0.45 electronvolts (eV), less than a millionth of the mass of an electron. The KATRIN experiment, launched in 2018 in Germany, will finalise its neutrino mass measurement campaign this year, having reached 1,000 days of data acquisition.

runners

In marathon runners, the myelin content of specific regions of the brain is reversibly reduced, according to a study carried out in the Basque Country. This observation is consistent with animal evidence suggesting that myelin lipids - a substance that surrounds neurons - can act as energy reserves in extreme metabolic conditions, as detailed by the authors in Nature Metabolism. The analysis is based on magnetic resonance imaging of eight men and two women before and after running a marathon. According to the study, the myelin content was fully recovered two months after the race.

rat

The seventh Annual Report of the COSCE Transparency Agreement, prepared by the European Animal Research Association, which analyses transparency in the use of animals for scientific experimentation in Spain in 2023, was presented today. According to the document, transparency is consolidated among the signatory institutions -168 in 2024- and all of them publish a statement on their websites on the use of animals. Public mention of the number and species used stands at 47%, compared to 38% the previous year.

gambling

According to a Lancet Public Health commission on commercial gambling, stricter regulations are needed on a global scale to reduce its impact on health and wellbeing worldwide. The authors argue that the harms caused by gambling are a threat to public health, exacerbated by the rapid expansion and digital transformation of the industry. These harms include physical and mental health problems, increased risk of suicide, gender-based violence and financial problems.

Nobel Medicina

The Karolinska Institute has awarded the Nobel Prize in Medicine or Physiology to Victor Ambros and Gary Ruvkun for the discovery of microRNAs, small RNA fragments that do not contain instructions for making proteins but instead participate in the regulation of gene expression. Their role is fundamental in processes such as cell differentiation, and their alteration can influence diseases like cancer.

FDA

The U.S. FDA has approved a new drug—called Cobenfy—to treat the symptoms of schizophrenia. Unlike traditional treatments, which are based on blocking the effects of dopamine, its mechanism of action simulates the effects of another neurotransmitter, acetylcholine. It is the first drug to be approved with a different mechanism of action in over 70 years.

dog

The impact of animal abandonment goes beyond the pets who suffer it, it is a public health, safety and funding issue as well. Although there have been some improvements in recent years, the experts consulted agree that the system continues to fail. In this guide, we analyze what has changed, who does this issue affect, and what must be improved.

children

Both sex and gender are associated with distinct networks in the brains of boys and girls, according to an analysis of brain images of 4,757 children in the US. Understanding these neurobiological patterns is important for identifying how sex and gender influence health and for developing specific diagnostic tools, the research team writes in Science Advances.

 

pills

The Lancet Psychiatry publishes the first meta-analysis of the incidence of antidepressant treatment discontinuation symptoms that includes data from more than 20,000 patients collected from 79 randomised controlled trials and observational studies. The study sought to distinguish between symptoms directly caused by medication discontinuation and other ‘non-specific’ symptoms that may be associated with patient or professional expectations (the nocebo effect). The study concludes that one in six to seven patients will experience one or more symptoms directly caused by stopping medication, and one in 35 are likely to experience severe symptoms.  

nose

A South Korean research team has designed an artificial olfactory system capable of distinguishing short-chain fatty acids with 90 % reliability. These molecules serve as diagnostic biomarkers for diseases such as stomach cancer and halitosis, according to the authors, whose research is published in Science Advances. The system - consisting of human olfactory receptors, artificial synapses and an artificial neural network - is able to distinguish combinations of molecules, compared to current techniques that detect single molecules and single compounds.